{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:07:51Z","timestamp":1791313671381,"version":"4.3.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clml.2019.10.007","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T18:52:24Z","timestamp":1571683944000},"page":"431-437.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-4164","authenticated-orcid":false,"given":"Daniella","family":"Klebaner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Koura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tzachanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.10.007_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: Clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5507\/bp.2005.040","article-title":"T-cell gamma\/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment","volume":"149","author":"Proch\u00e1zka","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.clml.2019.10.007_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002770050272","article-title":"Gamma\/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia","volume":"74","author":"Sallah","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2019.10.007_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3332\/ecancer.2018.872","article-title":"Use of PEG-asparaginase in a case of Hepatosplenic \u03b3\u03b4 T-cell lymphoma with long-term remission after stem cell transplantation","volume":"12","author":"Sun","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.clml.2019.10.007_bib5","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.hemonc.2014.09.006","article-title":"Hepatosplenic T-cell lymphoma: a case series","volume":"8","author":"Ashmore","year":"2015","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.clml.2019.10.007_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3816\/CLML.2010.n.021","article-title":"Hepatosplenic T-cell lymphoma in a young man with Crohn\u2019s disease: case report and literature review","volume":"10","author":"Ochenrider","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.10.007_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","article-title":"Hepatosplenic T-gammadelta lymphoma in a patient with Crohn\u2019s disease treated with azathioprine","volume":"44","author":"Navarro","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5694\/j.1326-5377.2008.tb02124.x","article-title":"Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn\u2019s disease","volume":"189","author":"Drini","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.clml.2019.10.007_bib10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/10428190701345433","article-title":"Hepatosplenic T-cell lymphoma in a patient with Crohn\u2019s disease who received infliximab therapy","volume":"48","author":"Zeidan","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10428199909058439","article-title":"Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection","volume":"33","author":"Lin","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lt.21748","article-title":"Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature","volume":"15","author":"Roelandt","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clml.2019.10.007_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.21062","article-title":"Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen","volume":"83","author":"Tey","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.10.007_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.critrevonc.2011.10.001","article-title":"Hepatosplenic gamma-delta T-cell lymphoma","volume":"83","author":"Ferreri","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clml.2019.10.007_bib15","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3109\/10428194.2012.740563","article-title":"Hepatosplenic \u03b1\u03b2 T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant","volume":"54","author":"Ba\u0161i\u0107 Kinda","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<983::AID-CNCR26>3.0.CO;2-W","article-title":"T\u00a0gamma\/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report","volume":"82","author":"Kraus","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.10.007_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0609.2004.00300.x","article-title":"Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature","volume":"73","author":"Niitsu","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2019.10.007_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.1995.tb05221.x","article-title":"Hepatosplenic gamma-delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up","volume":"90","author":"Garcia-Sanchez","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.10.007_bib19","first-page":"138","article-title":"Hepatosplenic gamma delta t cell lymphoma in two boys aged 5 months and 9 years","volume":"93","author":"Grunberg","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clml.2019.10.007_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pbc.21096","article-title":"Managing hepatosplenic \u03b3\u03b4 T-cell leukemia-lymphoma in children","volume":"49","author":"Lo Nigro","year":"2007","journal-title":"Pediat Blood Cancer"},{"key":"10.1016\/j.clml.2019.10.007_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00043426-200202000-00020","article-title":"Hepatosplenic T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl","volume":"24","author":"Rossbach","year":"2002","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib24","first-page":"1453","article-title":"Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma\/delta lymphoma","volume":"10","author":"Jonveaux","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.10.007_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic t \u03b3\/\u03b4 lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomomes Cancer"},{"key":"10.1016\/j.clml.2019.10.007_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10428199609054788","article-title":"Clinical and hematological characteristics of hepatosplenic T \u03b3\/\u03b4 lymphoma with isochromosome for long arm of chromosome 7","volume":"22","author":"Yao","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00000478-199707000-00006","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q","volume":"21","author":"Fran\u00e7ois","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clml.2019.10.007_bib29","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1038\/bcj.2015.43","article-title":"Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma","volume":"5","author":"Rashidi","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2019.10.007_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Lymphoma Working Party of the EBMT. Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.10.007_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","article-title":"Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience","volume":"14","author":"Chen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2019.10.007_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2019.10.007_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.10.007_bib34","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2019.10.007_bib35","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire","volume":"26","author":"Le Gouill","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428190109099342","article-title":"2\u2032-Deoxycoformycin for hepatosplenic \u03b3\u03b4 T-cell lymphoma","volume":"42","author":"Grigg","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190802087488","article-title":"Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha","volume":"49","author":"Humphreys","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib39","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00000478-199506000-00013","article-title":"Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type","volume":"19","author":"Wong","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib41","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/10428190310001609924","article-title":"Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with \u03b1\/\u03b2 hepatosplenic T-cell non-Hodgkin\u2019s lymphoma","volume":"45","author":"Chanan-Khan","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00043426-200406000-00008","article-title":"Hemophagocytic syndrome and hepatosplenic gamma-delta T-cell lymphoma with isochromosome 7q and 8 trisomy","volume":"26","author":"Chin","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib43","first-page":"ECR14","article-title":"Pentostatin (2\u2032-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2019.10.007_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2019.10.007_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ccr3.58","article-title":"Aggregating case reports: a way for the future of evidence-based health care?","volume":"2","author":"Jackson","year":"2014","journal-title":"Clin Case Rep"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2019.10.007_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood-2018-99-119944","article-title":"The novel SYK\/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in a phase 2a study in relapsed\/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"132","author":"Horwitz","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib47","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/10428194.2016.1247956","article-title":"Targeting histone deacetylases in T-cell lymphoma","volume":"58","author":"Moskowitz","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.10.007_bib48","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood-2017-08-802470","article-title":"Activity of the PI3K-\u03b4,\u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma","volume":"131","author":"Horwitz","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/asheducation-2015.1.545","article-title":"Zebras and hen\u2019s teeth: Recognition and management of rare T and NK lymphomas","volume":"2015","author":"Mehta-Shah","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2019.10.007_bib50","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib51","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow: A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"75","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2004.05144.x","article-title":"Bone marrow histopathology in peripheral T-cell lymphomas","volume":"127","author":"Dogan","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.10.007_bib55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib56","series-title":"Non-Hodgkin lymphoma","author":"Kahl","year":"2016"},{"key":"10.1016\/j.clml.2019.10.007_bib57","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(85)92930-7","article-title":"Malignant histiocytosis of the intestine: A T-cell lymphoma","volume":"2","author":"Isaacson","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2019.10.007_bib59","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clml.2019.10.007_bib61","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib62","article-title":"Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy","author":"Feller","year":"1988","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.clml.2019.10.007_bib63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00000478-199103000-00007","article-title":"Nasal lymphoma: A clincopathologic study with immunophenotypic and genotypic analysis","volume":"15","author":"Ferry","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib64","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: Definition, classification, and prognostic factors: An EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib65","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2007-04-060715","article-title":"Pathobiology of ALK+ anaplastic large-cell lymphoma","volume":"110","author":"Amin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib66","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib68","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1038\/ncomms10087","article-title":"Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress","volume":"7","author":"Malcolm","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clml.2019.10.007_bib69","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Sciences"},{"key":"10.1016\/j.clml.2019.10.007_bib70","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clml.2019.10.007_bib72","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2019.10.007_bib73","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: A report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.10.007_bib74","first-page":"316","article-title":"Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas","volume":"118","author":"Weiss","year":"1985","journal-title":"Am J Pathol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019320348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019320348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:42Z","timestamp":1761870882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019320348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2152265019320348"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.10.007","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}